ProMIS Neurosciences (NASDAQ:PMN) Trading Down 5%

ProMIS Neurosciences, Inc. (NASDAQ:PMN)’s share price traded down 5% during trading on Friday . The stock traded as low as $1.30 and last traded at $1.30. 16,788 shares traded hands during mid-day trading, a decline of 76% from the average session volume of 70,167 shares. The stock had previously closed at $1.37.

ProMIS Neurosciences Trading Down 5.0 %

The business has a fifty day moving average price of $1.58 and a two-hundred day moving average price of $1.79. The company has a market cap of $24.65 million, a price-to-earnings ratio of -1.76 and a beta of 0.65.

ProMIS Neurosciences (NASDAQ:PMN) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.01. On average, analysts anticipate that ProMIS Neurosciences, Inc. will post -0.24 EPS for the current year.

ProMIS Neurosciences Company Profile

ProMIS Neurosciences, Inc discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins.